Boston Scientific said its first-quarter net income roughly doubled as demand continued to grow worldwide for its stents, catheters and other cardiology devices.
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2026-04-22 04:13:00

















